What is a non-reassuring Cardiotocography (CTG)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is Non-Reassuring Cardiotocography (CTG)?

Non-reassuring CTG refers to fetal heart rate patterns that indicate potential fetal compromise, including fetal tachycardia, bradycardia, loss of heart rate variability, and variable or late decelerations. 1

Specific CTG Patterns Defining Non-Reassuring Status

Non-reassuring fetal status on CTG is characterized by the following abnormal patterns:

  • Fetal tachycardia: Baseline fetal heart rate persistently above 160 beats per minute 1
  • Fetal bradycardia: Baseline fetal heart rate persistently below 110 beats per minute 1
  • Loss of heart rate variability: Absence of normal beat-to-beat fluctuations in the fetal heart rate 1
  • Variable decelerations: Abrupt decreases in fetal heart rate that vary in timing, depth, and duration 1
  • Late decelerations: Gradual decreases in fetal heart rate with delayed onset after contraction begins, with the nadir occurring after the peak of contraction, indicating uteroplacental insufficiency and fetal hypoxemia 2

Clinical Significance and Urgency

The presence of non-reassuring fetal status should prompt urgent obstetric and medical review because emergency cesarean delivery may be necessary. 1

  • Non-reassuring CTG patterns can indicate fetal hypoxia and distress, though CTG has a high false positive rate 3
  • Late decelerations specifically indicate uteroplacental insufficiency and require immediate intervention, not continued observation 2
  • When accompanied by loss of variability, late decelerations are associated with fetal acidosis and increased risk of adverse neonatal outcomes 2

Context-Specific Interpretation

In Maternal Critical Illness (e.g., Sepsis, Cardiac Arrest)

  • Fetal surveillance provides a real-time measure of maternal end-organ perfusion and can help optimize maternal positioning, oxygenation, and mean arterial pressure 1
  • Non-reassuring fetal well-being could be the first sign of deterioration of maternal clinical condition and may signify impending maternal decompensation 1
  • Most non-reassuring tracings will improve with maternal hemodynamic optimization during initial stabilization 1

In Fetal Growth Restriction (FGR)

  • CTG monitoring frequency should be increased when FGR is complicated by absent or reversed end-diastolic velocity in umbilical artery Doppler 1, 4
  • In the setting of reversed end-diastolic velocity, heightened surveillance with CTG at least 1-2 times per day is recommended 1

Important Clinical Pitfalls

Many factors other than hypoxia can cause non-reassuring CTG traces, leading to high false positive rates and unnecessary interventions. 3

  • Non-reassuring CTG is the second leading cause of primary cesarean delivery in the United States 5
  • Prolonged fetal heart rate decelerations do not uniformly predict poor fetal outcome but can prompt unnecessary cesarean delivery 5
  • Significant inter- and intra-observer variability exists in CTG interpretation, which can lead to both under-treatment and over-treatment 6
  • When prolonged decelerations occur, rechecking fetal heart tones in the operating room may reveal return to baseline, potentially avoiding unnecessary cesarean delivery 5

Management Approach

When non-reassuring CTG patterns are identified:

  • Immediate interventions: Administer oxygen to the mother, position on left side, and discontinue oxytocin if being administered 2
  • Multidisciplinary team approach: Interpretation and management should involve obstetrics, maternal-fetal medicine, and anesthesia when appropriate 1
  • Consider multiple factors: Source of any maternal infection, gestational age, maternal and fetal health status, and patient preferences 1
  • Delivery indications: Non-reassuring cardiotocograph is an indication for delivery in preeclampsia and an indication for cesarean section in FGR with absent or reversed end-diastolic velocity 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Fetal Distress Management in Labor

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Towards Noninvasive Accurate Detection of Intrapartum Fetal Hypoxic Distress.

... International Conference on Wearable and Implantable Body Sensor Networks. International Conference on Wearable and Implantable Body Sensor Networks, 2021

Guideline

Cardiotocography Monitoring Guidelines for Fetal Growth Restriction

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

Is one abnormal pattern in cardiotocography (CTG) enough to consider it non-reassuring?
What is the most appropriate next step for a 32-year-old woman, gravida (number of times pregnant) 1, para (number of viable births) 0, at 42 weeks gestation, with spontaneous rupture of membranes, contractions, and a non-reassuring fetal heart rate tracing, who refuses emergency cesarean delivery despite understanding the risks of fetal asphyxia and death?
Is a cesarean delivery (C-section) indicated for a patient with protracted labor, currently at 8 centimeters (cm) cervical dilation, due to slow labor progression and the attending physician's (physician) impending unavailability?
What is the most appropriate next step in management for a pregnant woman presenting with decreased fetal movement?
What is the initial management for a pregnant woman at 31 weeks gestation with hypotension and moderate uterine tenderness, but a normal Cardiotocography (CTG) and cephalic presentation?
What is the recommended approach for occupational therapy in a preschooler?
What is the recommended management for chikungunya (Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)) arthritis?
What tumor markers should be sent in a patient with significant weight loss?
What is the initial dose and duration of etoricoxib (a nonsteroidal anti-inflammatory drug (NSAID)) for the management of chikungunya?
Is one abnormal pattern in cardiotocography (CTG) enough to consider it non-reassuring?
What is the initial management for a patient with type B aortic dissection?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.